The ratings agency also affirmed the “AA-” rating and removed select bonds from rating watch evolving, including:
- $132.575 million of series 2013 combination tax and revenue certificates of obligation
- $108.895 million of series 2013 general obligation refunding bonds
- $3.275 million of series 2009 general obligation refunding bonds
- $112.260 million of series 2008A general obligation bonds
The proceeds from the bonds will be used to refund the district’s outstanding 2008A general obligation bonds and to pay the costs of issuance. Officials expect to sell the bonds via negotiation the week of March 6.
The outlook is stable.
More articles on healthcare finance:
19 recent hospital outlook and credit rating actions
S&P revises University Medical Center of El Paso’s outlook to negative
S&P revises Good Shepherd Health System’s rating to ‘A’ on bonds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
